Phase I Trial of Cisplatin and Pemetrexed in Combination With Panobinostat in Advanced Solid Tumors, With Emphasis on Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 11 Jan 2018
At a glance
- Drugs Panobinostat (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer; Solid tumours
- Focus Adverse reactions
- 02 Jun 2017 Status changed from active, no longer recruiting to completed.
- 19 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 19 Jan 2017 Planned primary completion date changed from 1 Dec 2014 to 1 Jun 2017.